1. Impaired distal renal potassium handling in streptozotocin-induced diabetic mice.
- Author
-
Wu P, Li ST, Shu TT, Mao ZH, Fu WJ, Yang YY, Pan SK, Liu DW, Liu ZS, and Gao ZX
- Subjects
- Animals, Male, Mice, Inbred C57BL, Sodium-Glucose Transporter 2 Inhibitors pharmacology, Potassium Channels, Inwardly Rectifying metabolism, Potassium Channels, Inwardly Rectifying genetics, Mice, Diabetic Nephropathies metabolism, Diabetic Nephropathies etiology, Diabetic Nephropathies physiopathology, Kidney metabolism, Kidney drug effects, Kidney physiopathology, Hypokalemia metabolism, Amiloride pharmacology, Renal Elimination drug effects, Homeostasis, Solute Carrier Family 12, Member 3 metabolism, Solute Carrier Family 12, Member 3 genetics, Glucosides pharmacology, Streptozocin, Benzhydryl Compounds, Sodium-Glucose Transporter 2, Diabetes Mellitus, Experimental metabolism, Potassium metabolism, Potassium urine, Potassium, Dietary metabolism, Epithelial Sodium Channels metabolism
- Abstract
Diabetes is closely associated with K
+ disturbances during disease progression and treatment. However, it remains unclear whether K+ imbalance occurs in diabetes with normal kidney function. In this study, we examined the effects of dietary K+ intake on systemic K+ balance and renal K+ handling in streptozotocin (STZ)-induced diabetic mice. The control and STZ mice were fed low or high K+ diet for 7 days to investigate the role of dietary K+ intake in renal K+ excretion and K+ homeostasis and to explore the underlying mechanism by evaluating K+ secretion-related transport proteins in distal nephrons. K+ -deficient diet caused excessive urinary K+ loss, decreased daily K+ balance, and led to severe hypokalemia in STZ mice compared with control mice. In contrast, STZ mice showed an increased daily K+ balance and elevated plasma K+ level under K+ -loading conditions. Dysregulation of the NaCl cotransporter (NCC), epithelial Na+ channel (ENaC), and renal outer medullary K+ channel (ROMK) was observed in diabetic mice fed either low or high K+ diet. Moreover, amiloride treatment reduced urinary K+ excretion and corrected hypokalemia in K+ -restricted STZ mice. On the other hand, inhibition of SGLT2 by dapagliflozin promoted urinary K+ excretion and normalized plasma K+ levels in K+ -supplemented STZ mice, at least partly by increasing ENaC activity. We conclude that STZ mice exhibited abnormal K+ balance and impaired renal K+ handling under either low or high K+ diet, which could be primarily attributed to the dysfunction of ENaC-dependent renal K+ excretion pathway, despite the possible role of NCC. NEW & NOTEWORTHY Neither low dietary K+ intake nor high dietary K+ intake effectively modulates renal K+ excretion and K+ homeostasis in STZ mice, which is closely related to the abnormality of ENaC expression and activity. SGLT2 inhibitor increases urinary K+ excretion and reduces plasma K+ level in STZ mice under high dietary K+ intake, an effect that may be partly due to the upregulation of ENaC activity.- Published
- 2024
- Full Text
- View/download PDF